Literature DB >> 7574862

Visceral leishmaniasis: rapid response to AmBisome treatment.

O P Smith1, I M Hann, H Cox, V Novelli.   

Abstract

There appears to be an increase in imported cases of visceral leishmaniasis in Northern Europe; many are children infected on holiday in the Mediterranean. Making the diagnosis in young children can be difficult especially when an adequate travel history is not obtained at presentation. Two infants with visceral leishmaniasis are presented who were initially felt to have alternative diagnoses and who subsequently responded dramatically to a short course of liposomal amphotericin B (AmBisome).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7574862      PMCID: PMC1511183          DOI: 10.1136/adc.73.2.157

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  6 in total

Review 1.  Splenic aspiration. Review of the literature.

Authors:  P A Kager; P H Rees
Journal:  Trop Geogr Med       Date:  1983-06

2.  Visceral leishmaniasis in the Sudan: comparative parasitological methods of diagnosis.

Authors:  M Siddig; H Ghalib; D C Shillington; E A Petersen
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

3.  Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-centre trial.

Authors:  R N Davidson; L Di Martino; L Gradoni; R Giacchino; R Russo; G B Gaeta; R Pempinello; S Scott; F Raimondi; A Cascio
Journal:  Q J Med       Date:  1994-02

Review 4.  Selective primary health care: strategies for control of disease in the developing world. XIV. Leishmaniasis.

Authors:  P D Marsden
Journal:  Rev Infect Dis       Date:  1984 Sep-Oct

5.  Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar.

Authors:  M Mishra; U K Biswas; A M Jha; A B Khan
Journal:  Lancet       Date:  1994-12-10       Impact factor: 79.321

6.  Activity of liposomal amphotericin B (AmBisome) against Leishmania infantum and tissue distribution in mice.

Authors:  L Gradoni; R N Davidson; S Orsini; P Betto; M Giambenedetti
Journal:  J Drug Target       Date:  1993       Impact factor: 5.121

  6 in total
  2 in total

1.  Improvement of in vitro and in vivo antileishmanial activities of 2', 6'-dihydroxy-4'-methoxychalcone by entrapment in poly(D,L-lactide) nanoparticles.

Authors:  E C Torres-Santos; J M Rodrigues; D L Moreira; M A Kaplan; B Rossi-Bergmann
Journal:  Antimicrob Agents Chemother       Date:  1999-07       Impact factor: 5.191

2.  Visceral Leishmaniasis as a Possible Reason for Pancytopenia.

Authors:  Kira-Lee Koster; Hans-Jürgen Laws; Anja Troeger; Roland Meisel; Arndt Borkhardt; Prasad Thomas Oommen
Journal:  Front Pediatr       Date:  2015-06-29       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.